Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Patient Education

Reuters reports that an article in NEJM has identified possible negative side effects for the approved diabetes drug, Onglyza. Onglyza is a DPP-4 therapy, which blocks dipeptidyl peptidase to help enhance the body’s ability to lower blood sugar...
The Associated Press reports on a case of a 10-year-old cancer patient’s treatment course raising questions on the place of parental consent in treatment option decisions. As members of the Amish community, Sarah’s parents have decided to...
A study in The Journal of Studied on Alcohol and Drugs has found that the same genes may underly alcoholism and eating disorders. The study examined 6,000 adult twins who completed reports on alcohol abuse and binging/purging behavior. By comparing...